In NSCLC, carcinoembryonic antigen (CEA), squamous cell carcinoma related antigen (SCC) and cytokeratin 19 fragment (CYFRA 21-1) are commonly used for screening. This evidence concerns the gene SERPINB3 and non-small cell lung carcinoma.